Express Pharma November 16-30, 2017
India's Foremost Pharma & Biotech Magazine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Eris Lifesciences Q2 net up 35 per cent at Rs 93.14 cr
Consolidated total income of the company also rose to Rs 255.68 crore
Drug firm Eris Lifesciences has reported a 34.51 per cent…
Strides Shasun divests India brand business to Eris Lifesciences for Rs 500 cr
Net proceeds from this transaction will be used to pay down debt to the tune of Rs 400 crores
Strides Shasun and Eris…
Zydus Cadila gets US FDA nod for drug used to reduce swelling
The company will produce the drug at its formulations manufacturing facility in Moraiya, Ahmedabad
Zydus Cadila has received…
Cipla receives US FDA approval for generic Pulmicort Respules
The drug is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age
OPTEL Group bags loan worth CAD $68 m from Desjardins Group
The loan will allow OPTEL Group to extend its traceability service offer as well as diversify its activities in the healthcare,…
Mylan launches DURART R 450
This is the first FDC drug available to patients in India
Suven gets patents from HK, India, US on neurological molecule
The patents are valid till 2032, 2030 and 2034
Glenmark launches Kwitz
Kwitz helps smokers in smoking cessation and support the individual to achieve a smoke-free life
First made-in-India ‘digital pill’ to undergo clinical trial for diabetes
RSSDI partners with Wellthy Therapeutics to pioneer the adoption of diabetes digital therapeutics in India